An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function. - ...

Please provide your email address to receive an email when new articles are posted on . Depressive symptoms may be an early feature of preclinical Alzheimer’s disease. Associations between increasing ...

NEW YORK CITY (AP) - An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing ...

Transthyretin-mediated (ATTR) amyloidosis is a multisystem disease caused by the abnormal deposition of misfolded transthyretin protein as amyloid fibrils in various tissues. ATTR amyloidosis presents ...

Alzheimer’s may advance by breaking the brain’s internal clock—and resetting it could help fight the disease. Alzheimer’s disease often interferes with a person’s normal daily patterns. Early warning ...

A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer's disease.

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

The new study, published Wednesday in the journal Lancet Neurology, found that the risk of symptoms was cut in half for a small subset of 22 patients who had not shown any problems with memory or ...

The new study, published Wednesday in the journal Lancet Neurology, found that the risk of symptoms was cut in half for a small subset of 22 patients who had not shown any problems with memory or ...

(CNN) — For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can ...